David Goel Matrix Capital Management Company
David Goel is a co-founder of Matrix Capital Management, a technology-oriented investment firm with public and private market activities. Matrix is known for concentrated positions in software, semiconductor, and internet-related businesses. Goel’s filings are monitored for high-conviction technology themes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADAP
Adaptimmune Therapeutics
ADAP
|
+$65.8M |
| 2 |
Zillow
Z
|
+$65.2M |
| 3 |
TLND
Talend S.A. American Depositary Shares
TLND
|
+$30.3M |
| 4 |
Workday
WDAY
|
+$13.9M |
| 5 |
Constellation Brands
STZ
|
+$702K |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.96% |
| 2 | Technology | 31.08% |
| 3 | Communication Services | 21.66% |
| 4 | Consumer Discretionary | 6.61% |
| 5 | Industrials | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Netflix
NFLX
$331B
| $748M | 18.49% |
20,000,000
| – | – |
|
|
DATA
2
DELISTED
Tableau Software, Inc.
DATA
| $380M | 9.38% |
3,397,372
| – | – |
|
3
Incyte
INCY
$25.9B
| $319M | 7.88% |
4,616,847
| – | – |
|
|
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
| $298M | 7.37% |
3,866,852
| – | – |
|
|
ADAP
5
DELISTED
Adaptimmune Therapeutics
ADAP
| $276M | 6.82% |
20,362,011
+6,278,500
| +45% | +$65.8M |
|
6
CarGurus
CARG
$3.28B
| $267M | 6.61% |
4,801,048
| – | – |
|
|
ATVI
7
DELISTED
Activision Blizzard
ATVI
| $243M | 6.01% |
2,925,000
| – | – |
|
8
TransDigm Group
TDG
$66.4B
| $230M | 5.68% |
617,783
| – | – |
|
|
XYZ
9
Block Inc
XYZ
$49.4B
| $208M | 5.14% |
2,100,000
| – | – |
|
10
Exelixis
EXEL
$13.4B
| $177M | 4.38% |
10,000,000
| – | – |
|
|
11
Workday
WDAY
$49.4B
| $161M | 3.97% |
1,100,000
+100,000
| +10% | +$13.9M |
|
12
DaVita
DVA
$11.1B
| $139M | 3.43% |
1,940,000
| – | – |
|
13
Salesforce
CRM
$171B
| $127M | 3.14% |
800,000
| – | – |
|
|
14
Constellation Brands
STZ
$23.2B
| $122M | 3.01% |
565,500
+3,300
| +0.6% | +$702K |
|
15
Charter Communications
CHTR
$17.9B
| $73.3M | 1.81% |
225,000
| – | – |
|
16
Veeva Systems
VEEV
$40.3B
| $70.8M | 1.75% |
650,000
| – | – |
|
|
TLND
17
DELISTED
Talend S.A. American Depositary Shares
TLND
| $67.9M | 1.68% |
973,201
+481,115
| +98% | +$30.3M |
|
|
18
Zillow
Z
$8.07B
| $55.3M | 1.37% |
+1,250,000
| New | +$65.2M |
|
|
NEWR
19
DELISTED
New Relic, Inc.
NEWR
| $51.1M | 1.26% |
542,600
| – | – |
|
20
Blackbaud
BLKB
$2.16B
| $20.3M | 0.5% |
200,000
| – | – |
|
|
TRIL
21
DELISTED
Trillium Therapeutics Inc.
TRIL
| $13.3M | 0.33% |
2,288,560
| – | – |
|
Similar funds
David Goel's Q3 2018 Portfolio in Review
As of Q3 2018, David Goel held 21 positions worth $4.05B, up 15% from $3.52B the previous quarter. Its ten largest holdings account for 78% of the portfolio.
David Goel deployed $176M of net new capital in Q3 2018, opening 1 new position and adding to 4 existing holdings. Its largest new stake was Zillow: 1,250,000 shares worth $55.3M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.
- David Goel's largest Q3 2018 buy was Zillow: 1,250,000 shares worth $55.3M.
- David Goel added most to Adaptimmune Therapeutics in Q3 2018, an estimated $65.8M increase.
- David Goel's ten largest holdings make up 78% of its $4.05B portfolio in Q3 2018.
- David Goel opened 1 new position and closed 0 in Q3 2018.
- David Goel's portfolio value rose 15% quarter-over-quarter to $4.05B.
Based on Matrix Capital Management Company's 13F filing for Q3 2018, filed 14 Nov 2018.